NuVion Health at a Glance

NuVion presents itself as a research-only supplier. The business told Peptide Hub that Australian stock is held and dispatched from Melbourne, without overseas dropshipping.

Our review records detailed product pages, testing-status disclosures, a COA library and familiar online checkout options. These features help visitors distinguish between products with published laboratory evidence and those without it.

NuVion Health Score Breakdown

NuVion scores 83.7/100 on our core framework and receives 0/10 in additional Batch Testing points. It currently ranks second in our Australian Top 10.

Scores are reviewed monthly, or earlier when a vendor submits new evidence. Scores, positions and the framework may change following review. Affiliate commission is not a scoring category and vendors cannot pay for a higher position.

Strengths and Areas to Improve

Delivery and Packaging Observations

Peptide Hub placed a normal retail order at 7:30am on 7 September 2026. The parcel arrived interstate by 3pm on 8 September, approximately 31.5 hours after ordering. Same-day dispatch and very good service were recorded.

What We Observed

The parcel arrived in a protective black bubble mailer. Inside was a branded presentation box with a fitted foam insert holding the vial securely. Presentation was professional and the packaging protected the order received.

This was one observed order. Delivery and packaging findings do not establish product identity, purity, sterility or suitability for human use.

View full package photo ↗

This audit contributes to NuVion’s 15/15 Customer Experience score. It is assessed as service evidence, separately from laboratory testing and wider community reputation.

Independent Testing and Supplier COAs

The updated assessment records 11 qualifying independent test results and 29 supplier reports. NuVion earns 16/20 for Independent Testing under the published 10–14-result tier, and 4/5 for Supplier COAs & Transparency.

A laboratory independent of the manufacturer or vendor can perform a vendor-commissioned test. This is different from Peptide Hub independently purchasing and testing a retail sample. Report provenance should be labelled clearly.

Current Reported Results

The ten purity figures below were supplied in NuVion’s latest update. Their arithmetic mean is 99.654%, displayed as 99.65%. HCG report 234334 is the eleventh qualifying result and is measured in IU without a purity figure; it is excluded from the purity average.

These figures describe the reported tested samples. The average is not weighted by product sales or catalogue coverage, and it does not establish the purity, identity or safety of untested stock. The reports have not been newly authenticated as part of this copy update.

The earlier BPC-157 result of 98.08% remains historical evidence. NuVion reports that it was retested and replaced in September by the 99.93% result above. The replaced report is not counted as a twelfth current result.

Peptide Hub previously challenged blanket 99% wording in light of the earlier BPC-157 result. NuVion removed that blanket wording. That historical transparency response remains relevant, while the current average now uses the replacement result.

Supplier Documentation

The previous review noted that many older supplier reports had redacted Janoshik task numbers. NuVion said this protected its manufacturing source. Redaction limits public verification, so completeness and accessibility remain relevant to its 4/5 documentation assessment.

Independent testing and supplier COAs are assessed separately. Eleven qualifying results do not establish that every catalogue entry has been independently tested. Average reported purity is a separate descriptive metric and adds no extra points to the score.

Batch Testing

Batch Testing bonus: 0/10. This bonus recognises testing reports linked to current product batches and the vials supplied.

NuVion previously told Peptide Hub that individual vials did not carry batch numbers. It removed broader batch-to-vial wording after this was raised during review. No qualifying batch links are recorded in the current scoring inputs.

A zero bonus reflects the available evidence for those links. It does not establish that NuVion carries out no batch testing.

Pricing and Value

NuVion earns 15.4/20 for Price & Value. The final scoring inputs place its comparison pricing 1.7% below the comparison average on the products assessed.

This replaces the older September comparison figures in the previous review. The current comparison should not be read as a claim that every NuVion item is cheaper than every competitor, or as a total-basket comparison.

Prices, shipping fees and discount eligibility can change. The recorded comparison figure is presented as supplied, without applying an additional discount calculation to it.

Product Range and Stock Consistency

NuVion has 49 recorded product-and-strength entries, earning 9.9/10 for Product Range. Different strengths or formats may count separately, so the figure does not mean 49 distinct compounds.

The reviewed catalogue includes mainstream and less common research compounds. Examples recorded in the previous review include BPC-157, CJC-1295 No DAC, DSIP, Epithalon, GHK-Cu, Ipamorelin, KPV, MOTS-C, NAD+, Retatrutide, Selank, Semax, TB-500 and Tesamorelin.

These examples describe the reviewed catalogue rather than guaranteeing current stock. NuVion receives 5/5 for Stock Consistency, with products rarely recorded as out of stock in the comparison inputs.

Community Reputation

NuVion receives 10/15 for Community Reputation. Our inputs record positive early feedback, but its wider independent history remains shorter than that of several higher-scoring vendors.

The previous review described a verified-review section on NuVion’s website, invitations to genuine buyers without incentives and a follow-up request after delivery. This is useful feedback, while broader independent customer discussion remains important.

Website and Customer Experience

NuVion receives 15/15 for Customer Experience. The assessment combines its website and checkout experience, cooperative communication and the completed retail package audit.

• Detailed product pages with testing-status disclosures.
• A COA library and verification details where available.
• Card and digital wallet checkout recorded in the review.
• A dedicated support system and responsive direct communication.
• Published shipping information and research-use wording.
• Positive first-hand delivery and packaging observations.

NuVion also acted on earlier feedback by correcting batch-link wording and moderating manufacturing claims. Website quality contributes to the current customer-experience assessment; it is no longer a separate ten-point category.

Shipping, Checkout and Payment

The service details below were recorded in the supplied review. Confirm the vendor’s current shipping terms, charges and payment options before relying on them.

Our own retail order arrived interstate the following day. That observation supports the service assessment without guaranteeing the same timing for every order.

Business Structure and Manufacturing Disclosures

NuVion previously explained to Peptide Hub that the business operates across Australian and UK entities. The supplied review records a footer update identifying NuVion Health Ltd in England and Wales alongside the Australian entity, plus a displayed Melbourne address at 101 Collins Street.

These disclosures improve visibility of the business structure. A displayed contact address should not, by itself, be treated as confirmation of the physical location where stock is stored.

Peptide Hub also challenged earlier GMP wording. NuVion said its manufacturer had confirmed compliant production, but it did not itself hold the certification documents. The review records that its wording was moderated rather than treating certification as independently verified.

Final Verdict

NuVion Health scores 83.7/100 and ranks second in our current Australian Top 10. Its broad catalogue, strong recorded availability and customer experience are its leading features.

The updated inputs record eleven independent results and 29 supplier reports. Those are useful evidence signals, while testing coverage and report provenance still matter alongside report counts.

A longer independent community history, more complete testing coverage and clear links between reports, current batches and supplied vials would provide stronger grounds for a higher position.

NuVion Health FAQs